Reply to Cafiero et al. Comment on “Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672”
Author Contributions
Funding
Conflicts of Interest
References
- Kopańska, M.; Batoryna, M.; Bartman, P.; Szczygielski, J.; Banaś-Ząbczyk, A. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672. [Google Scholar] [CrossRef] [PubMed]
- Cafiero, C.; Micera, A.; Re, A.; Schiavone, B.; Benincasa, G.; Palmirotta, R. Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672. Int. J. Mol. Sci. 2022, 23, 2818. [Google Scholar] [CrossRef]
- Cafiero, C.; Micera, M.; Re, A.; Postiglione, L.; Cacciamani, A.; Schiavone, B.; Benincasa, G.; Palmirotta, R. Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection? Curr. Genom. 2021, 22, 557–563. [Google Scholar] [CrossRef]
- Villapol, S. Gastrointestinal symptoms associated with COVID-19: Impact on the gut microbiome. Transl. Res. 2020, 226, 57–69. [Google Scholar] [CrossRef] [PubMed]
- Akour, A. Probiotics and COVID-19: Is there any link? Lett. Appl. Microbiol. 2020, 71, 229–234. [Google Scholar] [CrossRef] [PubMed]
- Ho, D.; Low, R.; Tong, L.; Gupta, V.; Veeraraghavan, A.; Agrawal, R. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations. Ocul. Immunol. Inflamm. 2020, 28, 726–734. [Google Scholar] [CrossRef] [PubMed]
- Dockery, D.M.; Rowe, S.G.; Murphy, M.A.; Krzystolik, M.G. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J. Emerg. Med. 2020, 59, 137–140. [Google Scholar] [CrossRef] [PubMed]
- Matos, A.G.; Sarquis, I.C.; Santos, A.A.N.; Cabral, L.P. COVID-19: Risk of ocular transmission in health care professional. Rev. Bras. Med. Trab. 2021, 19, 82–87. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kopańska, M.; Szczygielski, J.; Bartman, P.; Banaś-Ząbczyk, A. Reply to Cafiero et al. Comment on “Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672”. Int. J. Mol. Sci. 2022, 23, 2822. https://doi.org/10.3390/ijms23052822
Kopańska M, Szczygielski J, Bartman P, Banaś-Ząbczyk A. Reply to Cafiero et al. Comment on “Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672”. International Journal of Molecular Sciences. 2022; 23(5):2822. https://doi.org/10.3390/ijms23052822
Chicago/Turabian StyleKopańska, Marta, Jacek Szczygielski, Paulina Bartman, and Agnieszka Banaś-Ząbczyk. 2022. "Reply to Cafiero et al. Comment on “Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672”" International Journal of Molecular Sciences 23, no. 5: 2822. https://doi.org/10.3390/ijms23052822